相关实验视频
Updated: Jan 10, 2026

Functional Characterization of Endogenously Expressed Human RYR1 Variants
Published on: June 9, 2021
与RYR1相关的肌肉病不仅涉及失调:从转录基因剖析的见解
Daniele Sabbatini1,2, Domenico Gorgoglione1, Giovanni Minervini3
1Neuromuscular Unit, Department of Neuroscience, University of Padova, 35128 Padova, Italy.
与瑞诺丁受体1相关的肌肉病变 (RYR1-RM) 涉及复杂的基因调节. RYR1变异影响细胞通路,如氧化应激和免疫激活,表明在中央核心疾病 (CCD) 和多微核疾病 (MmD) 中共享的机制和潜在的治疗点.
科学领域:
- 遗传学和分子生物学
- 神经学 神经学
- 细胞生物学 细胞生物学
背景情况:
- 与瑞诺丁受体1相关的肌肉病变 (RYR1-RM) 包含来自RYR1基因变异的各种疾病.
- 这项研究专门研究RYR1-RM患者的中央核心疾病 (CCD) 或多迷你核心疾病 (MmD) 组织病理学.
研究的目的:
- 通过使用RNA测序来研究CCD和MMD中RYR1变异影响的分子通路.
- 为了确定不同的RYR1-RM表型背后的共同和独特的分子机制.
主要方法:
- 来自CCD,MMD患者和健康对照的骨肌肉活检的RNA测序.
- 生物信息分析以确定差异表达的基因和丰富的途径.
主要成果:
- CCD患者在氧化应激反应,SMAD信号传递和亡途径中表现出丰富.
- 患有MMD的患者表现出免疫激活通路的丰富,具有改变的GTPase调节基因和转录抑制剂.
- 跨RYR1-RM表型的共享途径包括Wnt信号,免疫反应和氧化酸化.
结论:
- RYR1变异诱导复杂的基因调节,影响CCD和MMD中不同的细胞通路.
- 融合的分子机制,包括Wnt信号和免疫通路,可能是不同RYR1-RM呈现的基础.
- 了解这些途径为RYR1相关肌肉病变的潜在治疗策略提供了新的见解.
更多相关视频
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
12:43Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study
Published on: July 27, 2016
相关概念视频
Cardiomyopathy IV: Restrictive Cardiomyopathy
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Smooth Endoplasmic Reticulum
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Lysosomal Hydrolases
Cardiomyopathy I: Introduction and Classification